In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.

Moderna stock surged Wednesday after Oracle Chairman Larry Ellison praised the potential of AI in developing medicines.

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

BioNTech and Moderna COVID-19 vaccines use mRNA technology in their vaccines to protect us from the spread of the disease.

German biotech BioNTech is today presenting its 2025 strategic priorities and progress on the company’s pipeline of mRNA ...

Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approaches BioNTech aims to develop BNT327/PM8002 as a next-genera ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Other vaccine stocks also fell, with Novavax and BioNTech both ending more than 7% lower ... The company is betting on a ...

FROM face transplants to robot surgeons, Spain has achieved many medical discoveries and innovations in the last year.  The ...

OTTAWA, ON, Jan. 9, 2025 /PRNewswire/ - Esphera SynBio, a pre-clinical stage synthetic biology company, today announced a new project aimed at advancing next-generation mRNA vaccines. Using its ...

加星标，才能不错过每日推送！方法见文末插图 卡塔琳·卡里科（Katalin Karikó）是信使RNA（mRNA）及其医学潜力研究领域的先驱，这些潜力于新冠大流行期间在全球范围内得以展现。 她与同事德鲁·魏斯曼（Drew Weissman）共同研发了一种mRNA，最终使得辉瑞-拜恩泰科（BioNTech）公司和莫德纳公司的疫苗成为可能，这些疫苗拯救了全球数百万人的生命。凭借这一突破性成就，他们二人 ...